Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
1. Following local vasoconstriction-inducing stimuli, such as the cold pressor test (CPT), significant changes occur in haemodynamics, with a rise in arterial blood pressure and heart rate (HR) due to the activation of the sympathetic nervous system. Among the compensatory mechanisms to local ischaemia, the endogenous nucleoside adenosine (ADO) has been suggested to play a relevant role by contributing to sympathetic stimulation. The possibility was investigated that CPT-induced increases in plasma ADO levels were not only an expression of the increased production of ADO in the ischaemic area, but also a consequence of systemic sympathoexcitatory mechanisms, thus showing a bidirectional involvement of the mechanisms of ADO formation. 2. The CPT was performed in 15 volunteers and mean arterial blood pressure (MABP) and HR were evaluated, together with plasma levels of noradrenaline (NA) and ADO in the tested and contralateral arm. The 15 subjects were then divided into three groups of five that were treated with either 5 mg transdermal clonidine weekly, 100 mg atenolol daily or 600 mg aminophylline twice daily. After 1 week treatment, the same test was repeated in the respective groups. 3. The CPT induced a rise in MABP and HR and an increase in plasma levels of NA and ADO. Increases in ADO were more pronounced in the tested arm. Clonidine blunted the haemodynamic response and NA release, while increases in ADO increase were reduced to a greater extent in the contralateral arm rather than the tested arm. Atenolol only affected MABP and HR without any effect on NA and ADO levels. Theophylline did not show any effect on CPT-induced changes. 4. In conclusion, local vasoconstriction and ischaemia induced in one arm following CPT are associated with haemodynamic changes dependent on the activation of the sympathetic system. The observed increase in plasma levels of ADO seems to be, in part, a direct expression of local responses to ischaemia (pre-dominant in the tested arm), but also appears as the consequence of systemic sympathoexcitatory mechanisms. Such increases in ADO are not dependent on a beta 1-adrenoceptor-mediated mechanism. Finally, theophylline, at a therapeutic dose, has no effect on the response to CPT.
1. Following local vasoconstriction-inducing stimuli, such as the cold pressor test (CPT), significant changes occur in haemodynamics, with a rise in arterial blood pressure and heart rate (HR) due to the activation of the sympathetic nervous system. Among the compensatory mechanisms to local ischaemia, the endogenous nucleoside adenosine (ADO) has been suggested to play a relevant role by contributing to sympathetic stimulation. The possibility was investigated that CPT-induced increases in plasma ADO levels were not only an expression of the increased production of ADO in the ischaemic area, but also a consequence of systemic sympathoexcitatory mechanisms, thus showing a bidirectional involvement of the mechanisms of ADO formation. 2. The CPT was performed in 15 volunteers and mean arterial blood pressure (MABP) and HR were evaluated, together with plasma levels of noradrenaline (NA) and ADO in the tested and contralateral arm. The 15 subjects were then divided into three groups of five that were treated with either 5 mg transdermal clonidine weekly, 100 mg atenolol daily or 600 mg aminophylline twice daily. After 1 week treatment, the same test was repeated in the respective groups. 3. The CPT induced a rise in MABP and HR and an increase in plasma levels of NA and ADO. Increases in ADO were more pronounced in the tested arm. Clonidine blunted the haemodynamic response and NA release, while increases in ADO increase were reduced to a greater extent in the contralateral arm rather than the tested arm. Atenolol only affected MABP and HR without any effect on NA and ADO levels. Theophylline did not show any effect on CPT-induced changes. 4. In conclusion, local vasoconstriction and ischaemia induced in one arm following CPT are associated with haemodynamic changes dependent on the activation of the sympathetic system. The observed increase in plasma levels of ADO seems to be, in part, a direct expression of local responses to ischaemia (pre-dominant in the tested arm), but also appears as the consequence of systemic sympathoexcitatory mechanisms. Such increases in ADO are not dependent on a beta 1-adrenoceptor-mediated mechanism. Finally, theophylline, at a therapeutic dose, has no effect on the response to CPT.
The classical sulphonylurea derivative glibenclamide is widely prescribed for the treatment of non-insulindependent diabetes mellitus (NIDDM). The mechanism of action of this drug is based on an augmented release of insulin from the beta cells of the pancreas, triggered by the closing of so-called ATP-dependent potassium channels (ATP: adenosine'5-triphosphate) [1]. This ultimately results in an influx of calcium via opening of voltage-dependent calcium-ion channels, and the subsequent binding of calcium ions to calmodulin triggers the exocytosis of insulin-containing secretory granules. The central issue of this presentation is the fact that the occurrence of K ATP -channels is not restricted to the pancreatic beta cells. These particular ion channels occur in several organ systems, including the cardiovascular system [2,3].The open state probability of K ATP -channels is dependent on the cytosolic concentration of ATP. During hypoxia and/or ischaemia, the cytosolic concentration of ATP falls which directly results in opening of K ATP -channels. The subsequent efflux of potassium induces hyperpolarization of the cell membrane which shortens the action potential in the myocardial cell leading to a reduction in the contractile amplitude of myocardial cells. In vascular smooth muscle cells, opening of K ATP -channels and subsequent hyperpolarization exerts relaxation of these cells, resulting in an obvious vasodilator response.The vascular smooth muscle cell K ATP -channels can be opened pharmacologically by potassium-channel-opening drugs such as cromakalim and the classical vasodilator drug diazoxide [3]. Glibenclamide is able to reduce the vasodilator response to these K ATP channel-opening drugs, indicating the ability to block vascular K ATP -channels. Apart from the interaction with K ATP -channel-opening drugs, glibenclamide has also been reported to inhibit the vasodilator response to adenosine, and to (endothelium-dependent) vasodilators such as acetylcholine, vasoactive intestinal peptide and insulin [4]. Also in the myocardial cell, glibenclamide is able to reduce the response to K ATP -channel-opening agents [4].Animal experiments have shown that the ischaemia-induced opening of myocardial K ATP -channels is an endogenous cardioprotective mechanism against ischaemia and reperfusion damage. In several ischaemia models glibenclamide increased infarct size [5,6]. On the other hand blockade of the sulphonylurea receptor is associated with a reduction in ischaemia-related arrhythmias [4]. Not only myocardial K ATPchannels are involved in the response to ischaemia. Other investigators have demonstrated that the vascular smooth muscle cell response to ischaemia is also inhibited by sulphonylurea derivatives, represented by a reduction of the post-occlusive hyperaemic response after pretreatment with glibenclamide.Interestingly, the newly developed sulphonylurea derivative glimepiride seems to act more selectively, since its hypoglycaemic action is more pronounced than that of glibenclamide, whereas animal dat...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.